查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1291582

液体活检市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球液体活检市场规模达到18亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到43亿美元，在2023-2028年期间表现出15.3%的增长率（CAGR）。

液体活检是一种非侵入性的替代手术活检的方法，使医生能够通过血液样本获得关于肿瘤的信息并制定相应的治疗计划。它可以反映肿瘤基因表达谱的变化，并为个体化治疗提供一个强大的基础。它有助于早期诊断筛选、肿瘤异质性和耐药性。除此之外，它还能检测表皮生长因子受体（EGFR）的基因突变，这些突变发生在非小细胞肺癌（NSCLC）患者中。

液体活检市场趋势：

由于久坐的生活方式和烟草消费的增加，全球癌症患者的数量激增。这一点，加上个人对癌症诊断中先进的微创（MI）程序的认识不断提高，是推动市场发展的关键因素之一。此外，一些国家的管理当局正在资助研究和开发（R&D）活动，以鼓励引进先进的癌症解决方案。这些当局也对医疗行业的发展进行了大量投资，这为行业参与者提供了有利可图的增长机会。除此之外，主要的市场参与者正专注于产品的推出，在全球范围内发展个性化医疗。他们也在整合液体活检的技术进步，以提供更好的程序工作流程和产出。再加上越来越多地采用基于血液的活检测试来进行早期肿瘤检测，这对市场产生了积极的影响。此外，外泌体在肿瘤学临床诊断中的使用越来越多，以提供高精确度和减少程序时间，这也催化了对液体活检的需求。数字聚合酶链反应（PCR）和基于下一代测序（NGS）技术的快速发展是推动市场增长的诱导因素。

本报告回答的关键问题：

  • 迄今为止，全球液体活检市场的表现如何，在未来几年将如何表现？
  • COVID-19对全球液体活检市场的影响是什么？
  • 主要的区域市场是什么？
  • 基于产品和服务的市场细分是什么？
  • 基于循环生物标志物的市场细分是什么？
  • 基于癌症类型的市场细分是什么？
  • 基于终端用户的市场细分是什么？
  • 该行业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球液体活检市场的结构是什么，谁是主要的参与者？
  • 该行业的竞争程度如何？

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球液体活检市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按产品和服务分類的市场

  • 试剂盒和试剂
    • 市场趋势
    • 市场预测
  • 平台和仪器
    • 市场趋势
    • 市场预测
  • 服务
    • 市场趋势
    • 市场预测

第7章 ：按循环生物标志物分類的市场

  • 循环肿瘤细胞
    • 市场趋势
    • 市场预测
  • 细胞外囊泡
    • 市场趋势
    • 市场预测
  • 循环肿瘤DNA
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第8章：按癌症类型分類的市场

  • 肺癌
    • 市场趋势
    • 市场预测
  • 乳腺癌
    • 市场趋势
    • 市场预测
  • 结直肠癌
    • 市场趋势
    • 市场预测
  • 前列腺癌
    • 市场趋势
    • 市场预测
  • 肝癌
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第九章：按终端用户分類的市场

  • 医院和实验室
    • 市场趋势
    • 市场预测
  • 学术和研究中心
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第十章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十一章 ：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十二章 ：价值链分析

第十三章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十四章：价格分析

第十五章 ：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • ANGLE plc
    • Biocept Inc.
    • Bio-Rad Laboratories Inc
    • Epigenomics AG
    • Exact Sciences Corporation
    • F.Hoffmann-La Roche AG
    • Guardant Health Inc.
    • Illumina Inc.
    • MDxHealth SA
    • Menarini Silicon Biosystems
    • QIAGEN N.V.
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A5125

The global liquid biopsy market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.

Liquid biopsy is a non-invasive alternative to surgical biopsies enabling doctors to obtain information about a tumor through a blood sample and plan the treatment accordingly. It can reflect changes in tumor gene expression profile and offer a robust base for individualized therapy. It assists in the early diagnosis screening, tumor heterogeneity and drug resistance. Besides this, it also detects epidermal growth factor receptor (EGFR) gene mutations, which occur among patients with non-small cell lung cancer (NSCLC).

Liquid Biopsy Market Trends:

Due to sedentary lifestyles and rising tobacco consumption, there is a surge in the number of cancer patients across the globe. This, along with the growing awareness among individuals about advanced minimally invasive (MI) procedures in cancer diagnostics, represents one of the key factors driving the market. Moreover, governing authorities of several countries are financing research and development (R&D) activities to encourage the introduction of advanced cancer solutions. These authorities are also considerable investing in the development of the healthcare industry, which is offering lucrative growth opportunities to industry players. Apart from this, key market players are focusing on product launches to develop personalized medicine worldwide. They are also integrating technological advancements in liquid biopsy to offer better procedure workflow and output. This, coupled with the rising adoption of blood-based biopsy tests for early tumor detection, is positively influencing the market. Additionally, the increasing usage of exosomes for clinical diagnosis in oncology to provide high accuracy and reduced procedural time is catalyzing the demand for liquid biopsy. Growth-inducing factors projected to impel the market growth are rapid development in digital polymerase chain reaction (PCR) and next-generation sequencing (NGS) based technology.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global liquid biopsy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and service, circulating biomarker, cancer type and end user.

Breakup by Product and Service:

Kits and Reagents

Platforms and Instruments

Services

Breakup by Circulating Biomarker:

Circulating Tumor Cells

Extracellular Vesicles

Circulating Tumor DNA

Others

Breakup by Cancer Type:

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Liver Cancer

Others

Breakup by End User:

Hospitals and Laboratories

Academic and Research Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc, Epigenomics AG, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Guardant Health Inc., Illumina Inc., MDxHealth SA, Menarini Silicon Biosystems, QIAGEN N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global liquid biopsy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global liquid biopsy market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product and service?
  • What is the breakup of the market based on the circulating biomarker?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global liquid biopsy market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Liquid Biopsy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Kits and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Platforms and Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Circulating Biomarker

  • 7.1 Circulating Tumor Cells
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Extracellular Vesicles
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Circulating Tumor DNA
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Cancer Type

  • 8.1 Lung Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Breast Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Colorectal Cancer
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Liver Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 ANGLE plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Biocept Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 Bio-Rad Laboratories Inc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Epigenomics AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Exact Sciences Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F.Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Guardant Health Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 MDxHealth SA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Menarini Silicon Biosystems
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 QIAGEN N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Liquid Biopsy Market: Major Drivers and Challenges
  • Figure 2: Global: Liquid Biopsy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Liquid Biopsy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Liquid Biopsy Market: Breakup by Product and Service (in %), 2022
  • Figure 5: Global: Liquid Biopsy Market: Breakup by Circulating Biomarker (in %), 2022
  • Figure 6: Global: Liquid Biopsy Market: Breakup by Cancer Type (in %), 2022
  • Figure 7: Global: Liquid Biopsy Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Liquid Biopsy Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Liquid Biopsy (Kits and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Liquid Biopsy (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Liquid Biopsy (Platforms and Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Liquid Biopsy (Platforms and Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Liquid Biopsy (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Liquid Biopsy (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Liquid Biopsy (Circulating Tumor Cells) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Liquid Biopsy (Circulating Tumor Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Liquid Biopsy (Extracellular Vesicles) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Liquid Biopsy (Extracellular Vesicles) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Liquid Biopsy (Circulating Tumor DNA) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Liquid Biopsy (Circulating Tumor DNA) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Liquid Biopsy (Other Circulating Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Liquid Biopsy (Other Circulating Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Liquid Biopsy (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Liquid Biopsy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Liquid Biopsy (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Liquid Biopsy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Liquid Biopsy (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Liquid Biopsy (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Liquid Biopsy (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Liquid Biopsy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Liquid Biopsy (Liver Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Liquid Biopsy (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Liquid Biopsy (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Liquid Biopsy (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Liquid Biopsy (Hospitals and Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Liquid Biopsy (Hospitals and Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Liquid Biopsy (Academic and Research Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Liquid Biopsy (Academic and Research Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Liquid Biopsy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Liquid Biopsy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia-Pacific: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia-Pacific: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Liquid Biopsy Market: Breakup by Country (in %), 2022
  • Figure 89: Middle East and Africa: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Global: Liquid Biopsy Industry: SWOT Analysis
  • Figure 91: Global: Liquid Biopsy Industry: Value Chain Analysis
  • Figure 92: Global: Liquid Biopsy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Liquid Biopsy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Liquid Biopsy Market Forecast: Breakup by Product and Service (in Million US$), 2023-2028
  • Table 3: Global: Liquid Biopsy Market Forecast: Breakup by Circulating Biomarker (in Million US$), 2023-2028
  • Table 4: Global: Liquid Biopsy Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
  • Table 5: Global: Liquid Biopsy Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Liquid Biopsy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Liquid Biopsy Market: Competitive Structure
  • Table 8: Global: Liquid Biopsy Market: Key Players